Navigation Links
Women Win Legal Battle Over Treatment Of Breast Cancer

For many hundreds of women’s fight against the cancer of breast the ruling by the courts has opened means of treatment. Three senior Court of Appeal judges said // yesterday that the policy adopted by the Swindon NHS Primary Care Trust, of funding treatment with the drug Herceptin only in "exceptional circumstances", was irrational because it was not supported by any personal or clinical distinctions among eligible patients. The trust itself had insisted that financial considerations did not underlie its policy.

Ann Marie Rogers, a breast cancer patient, has won a landmark ruling that her local hospital acted unlawfully in refusing to supply her with a potentially life-saving treatment.

Jeremy Hughes, the chief executive of Breakthrough Breast Cancer, welcoming the judgment, said that, it could be hoped that this would send out clear messages to all PCTs, that Herceptin should be prescribed on the basis of clinical need, not cost. Herceptin is already being licensed for use in women with advanced breast cancer, and studies show that it may also be effective in preventing a recurrence of early-stage forms of the disease. The makers, of the drug, Roche, have claimed to have applied for a licence for early-stage treatment with Herceptin and the National Institute for Clinical Excellence has agreed to fast-track its appraisal of which patients should receive it on the NHS, but these two decisions are not expected until later this year. Till such time the PCTs have been told to act at their own discretion, and this has lead to widespread disparities in who receives the drug. It has been found in survey that only 10 % of eligible patients in some areas are given access to Herceptin, compared to 90% in others.

The ruling stated that it is now a matter for the PCT to reconsider its policy and to formulate a lawful policy upon which to base decisions in particular cases. The chief executive of Swindon Primary Care Trust, said, that they we lcome the clarity given by the court on the use of Herceptin. He stated that with this new judgment they would now include and restructure their policy by taking into consideration the points made by the court. The PCT will continue to treat all patients now and in the future with care and consideration, he said.

Meanwhile the Dr David Miles The British breast cancer expert who helped develop Herceptin last night criticised the growing hype over the so-called wonder drug. In his statement after the court ruling he said that a wonder drug is something that cures everyone who takes it with very few problems. Explaining that it is clearly not the case with Herceptin. He explained that people think that it would halve the rate of recurrence of cancer, but it wouldn’t be so impressive when people understand that there could be maybe a fall from 20% to 10%.

His concerns were echoed by other senior doctors, among them Joe Collier, the professor of medicines policy at St George's Hospital Medical School, London, and David Kerr, professor of clinical pharmacology and cancer therapy at Oxford University.


Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:

(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... new study carried out by the University of Toronto and the University of British ... number of hospitalizations for head injuries. The article explains that part of the reason ...
(Date:11/27/2015)... ... 2015 , ... A team of Swiss doctors has released a report on ... just posted the findings on the website. Click here to read the details ... mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion ... off of their purchase of lice treatment product. In addition, customers will receive a ... company spokesperson. “Finding lice is a sure way to ruin the holidays, so we ...
(Date:11/27/2015)... LOS ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only ... age of 30 (see Table 1-1 ). More than 3.7 billion people under ... simplex virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Competitive Intelligence, ... --> ) has ... Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... Research and Markets ( ) has announced the ... Type (Dressings, Therapy Devices, Active Wound Care), Application (Surgical ... Geography - Global Forecast to 2020" report to ... --> The purpose of this report is to ... advanced wound care market. It involves deep dive analysis ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... of the "Self Administration of High Viscosity ... ) has announced the addition of ... report to their offering. --> ... the addition of the "Self Administration of ...
Breaking Medicine Technology: